Clinical Trial Update: FOCUS Fatigue Outcome in Copaxone USers [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reports on fatigue outcomes in people with multiple sclerosis treated with Copaxone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• COPAXONE (GLATIRAMER ACETATE)

Snippet

Sponsor: Sanofi | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED